linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Book Closure  
Bafna Pharmaceuticals Ltd.
 
From Date To Date Purpose
19-Sep-24 25-Sep-24   A.G.M. 
22-Jul-22 28-Jul-22   A.G.M. 
07-Aug-21 14-Aug-21   A.G.M. 
25-Jul-20 31-Jul-20   A.G.M. 
24-Jun-19 27-Jun-19   A.G.M. 
23-Sep-18 29-Sep-18   A.G.M. 
24-Sep-17 30-Sep-17   A.G.M. 
22-Sep-16 27-Sep-16   A.G.M. 
23-Sep-15 29-Sep-15   A.G.M. 
06-Sep-14 10-Sep-14   A.G.M. 
21-Sep-13 30-Sep-13   Rs.0.6000 per share(6%)Final Dividend & A.G.M. 
22-Sep-12 27-Sep-12   A.G.M. 
21-Sep-11 23-Sep-11   A.G.M. 
21-Aug-10 23-Aug-10   A.G.M. 
23-Sep-09 24-Sep-09   A.G.M. 
23-Sep-08 23-Sep-08   A.G.M. 
Page 1 of 1
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.